The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index; 69 of the 102 sources its claims cite were checked for support.
Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep
Open accessAbstract
As the brain transitions from wakefulness to sleep, processing of external information diminishes while restorative processes, such as glymphatic removal of waste products, are activated. Yet, it is not known what drives brain clearance during sleep. We here employed an array of technologies and identified tightly synchronized oscillations in norepinephrine, cerebral blood volume, and cerebrospinal fluid (CSF) as the strongest predictors of glymphatic clearance during NREM sleep. Optogenetic stimulation of the locus coeruleus induced anti-correlated changes in vasomotion and CSF signal. Furthermore, stimulation of arterial oscillations enhanced CSF inflow, demonstrating that vasomotion acts as a pump driving CSF into the brain. On the contrary, the sleep aid zolpidem suppressed norepinephrine oscillations and glymphatic flow, highlighting the critical role of norepinephrine-driven vascular dynamics in brain clearance. Thus, the micro-architectural organization of NREM sleep, driven by norepinephrine fluctuations and vascular dynamics, is a key determinant for glymphatic clearance.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Norepinephrine (NE) oscillations from the locus coeruleus drive slow vasomotion, and these arterial constriction–dilation cycles act as a pump for cerebrospinal fluid (CSF) influx and glymphatic clearance during NREM sleep. The sleep aid zolpidem suppresses NE oscillations and reduces glymphatic tracer influx despite increasing sleep.
Key findings
- NE and blood albumin signals were anti-correlated across wake, NREM, and REM; blood albumin lagged NE by 0.29±0.6 s in wakefulness and 0.69±0.3 s in NREM sleep. NE oscillation trough-to-peak amplitude was higher in NREM sleep than wakefulness or REM sleep, and NE–blood correlation variability was lower in NREM (SD 0.06) than wake/REM (SD 0.13).
- Optogenetic locus coeruleus stimulation increased NE and decreased blood albumin in a stimulation-frequency-dependent manner; panadrenergic blockade (PPA) abolished the blood decrease. LC inhibition decreased NE and increased blood albumin. The NE-insensitive GRABNEmut peak during NREM infraslow oscillation was 7.2% of the GRABNE2m peak.
- CSF tracer was anti-correlated with blood albumin and highest on average in NREM sleep and lowest in REM sleep. LC stimulation increased CSF tracer in a frequency-dependent manner, and this increase was abolished by PPA. NE, blood, and CSF showed phase-locked infraslow oscillations at 0.01–0.02 Hz in NREM sleep (REM: 0.02–0.03 Hz; wake: below ~0.005 Hz).
- Direct optogenetic stimulation of vascular smooth muscle cells increased vascular oscillation frequency (from 50 s to 10 s period) and enhanced CSF tracer penetration in the stimulated hemisphere in hippocampus and dorsal cortex, but not in ventral surface far from stimulation. Glymphatic clearance correlated negatively with micro-arousal frequency, not with total NREM time, REM time, wake time, NREM delta/theta/sigma/beta power, or wake bouts >20 s. Zolpidem (5 mg/kg) reduced NE oscillation magnitude, decreased baseline prefrontal NE by approximately 50%, increased micro-arousals not associated with NE peaks by ~70%, and lowered glymphatic tracer influx.
Methods
- Freely behaving mice (wildtype C57BL/6, TH-Cre, Sm22-Cre:Ai32-ChR2 and controls) were used with EEG/EMG, fiber-optic cannula, cisterna magna catheter, and chronic liver-secreted fluorescent albumin labeling. “Flow fiber photometry” combined GRABNE2m NE biosensor, blood albumin, and CSF tracers (3 kDa TMR or FITC dextran) to track NE, vascular, and CSF dynamics across wake, NREM, and REM sleep without head fixation or anesthesia.
- Optogenetic manipulations targeted locus coeruleus (ChR2 or ArchT) or vascular smooth muscle cells (Sm22-Cre:Ai32-ChR2); pharmacological blockade used prazosin, propranolol, and atipamezole (PPA). Miniscope imaging measured artery/vein diameter and NE; SPECT/CT with intrastriatal [99mTc]-DTPA quantified glymphatic clearance; microdialysis measured prefrontal NE; zolpidem was tested at 5 mg/kg.
- Analyses included sleep scoring, cross-correlations, power spectral density, time-locking to EEG sigma peaks and micro-arousals, correlation of clearance/influx with sleep parameters, and standard parametric/nonparametric statistics with outlier removal.
Limitations
- The paper states that hemoglobin absorption may alter the CSF tracer trace during REM sleep, so the study focused on NREM sleep; it also states that REM sleep’s contribution to glymphatic function could not be detected and remains unresolved.
- The paper states that human confirmation is needed and that it is difficult to know whether zolpidem suppresses NE dynamics in human subjects; it also notes that anesthesia differs from natural sleep and was avoided here.
- Evident from the text: the causal evidence is mainly from mouse optogenetics and correlational sleep/clearance analyses, with local optogenetic stimulation effects and no direct human glymphatic clearance measurement.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
69 of 102 cited sources checked · 23 supported · 1 flagged · accuracy not yet measured
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Multiple studies have proven the existence of a glymphatic system in humans10,16,105–107.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > Translational aspects
What the sources say
- Not checked — no full text of the sourcecites [10] Zhou Y, Cai J, Zhang W, Impairment of the Glymphatic Pathway and Putative Meningeal Lymphatic Vessels in the Aging Human. Ann Neurol. 2020; 87(3): 357– 369. doi: 10.1002/ana.25670 31916277 source
- Partly supportedcites [16] Eide PK, Vinje V, Pripp AH, Mardal K-A, Ringstad G. Sleep deprivation impairs molecular clearance from the human brain. Brain. 2021; 144(3): 863– 874. doi: 10.1093/brain/awaa443 33829232 sourceExperimental — accuracy not yet measured
The Discussion cites multiple human tracer studies as support for the glymphatic concept. It also says the mechanisms remain debated and that MRI cannot establish the tracer’s exact route through brain tissue. Those qualifications do not support the claim that the system’s existence in humans has been proven. (LLM, conf=0.88)
- Partly supportedcites [105] Eide PK, Vatnehol SAS, Emblem KE, Ringstad G. Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes. Sci Rep. 2018; 8(1): 7194. doi: 10.1038/s41598-018-25666-4 29740121 PMC5940793 sourceExperimental — accuracy not yet measured
The Introduction says a previous human MRI study showed glymphatic contrast enhancement, and the Discussion reports this study’s in-vivo evidence of tracer drainage to cervical lymph nodes alongside glymphatic enhancement. Those findings support evidence for a human glymphatic system, but the paper calls them evidence rather than proof and notes that aspects of glymphatic circulation remain controversial (Discussion; page unavailable). (LLM, conf=0.86)
- Disputedcites [106] Demiral ŞB, Tomasi D, Sarlls J, Apparent diffusion coefficient changes in human brain during sleep – Does it inform on the existence of a glymphatic system? Neuroimage. 2019; 185: 263– 273. doi: 10.1016/j.neuroimage.2018.10.043 30342236 PMC6289767 sourceExperimental — accuracy not yet measured
The Introduction says it is currently unknown whether a glymphatic system as described in rodents exists in the human brain. The Discussion describes the human findings as preliminary and not conclusive, and other clinical studies as providing indirect evidence—not proof. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [107] Yang G, Deng N, Liu Y, Gu Y, Yao X. Evaluation of Glymphatic System Using Diffusion MR Technique in T2DM Cases. Front Hum Neurosci. 2020; 14: 1– 7. doi: 10.3389/fnhum.2020.00300 32922272 PMC7456821 sourceExperimental — accuracy not yet measured
The Introduction describes the glymphatic system as a discovered brain system, and the Discussion refers to earlier human tracer studies. But the paper’s own human study uses diffusion MRI as an indirect measure of presumed glymphatic activity; its Discussion says the findings ‘may indicate’ damage to the system. It does not establish that multiple studies have proven the system’s existence in humans. (LLM, conf=0.84)
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe cited sources support only part of this claim — read each source’s verdict below.
In the paper
“NREM sleep is characterized by regular oscillations in brain norepinephrine (NE) levels with a frequency in the range of ~0.02 Hz32–34.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Introduction
What the sources say
- Partly supportedcites [32] Osorio-Forero A, Cardis R, Vantomme G, Noradrenergic circuit control of non-REM sleep substates. Curr Biol. 2021; 31(22): 5009– 5023. doi: 10.1016/j.cub.2021.09.041 34648731 sourceExperimental — accuracy not yet measured
The section “Thalamic NA levels during NREMS are high and fluctuate on infraslow time intervals” (p. 6) reports recurrent fluctuations in norepinephrine levels measured in the thalamus of sleeping mice. The Results (p. 4) place the associated sigma-power cycle at about 50 seconds, or 0.02 Hz. The evidence supports the approximate timescale, but the claim presents it as a general feature of brain norepinephrine during NREM sleep rather than a finding measured in mouse thalamus. (LLM, conf=0.82)
- Partly supportedcites [33] Kjaerby C, Andersen M, Hauglund N, Memory-enhancing properties of sleep depend on the oscillatory amplitude of norepinephrine. Nat Neurosci. 2022; 25(8): 1059– 1070. doi: 10.1038/s41593-022-01102-9 35798980 PMC9817483 sourceExperimental — accuracy not yet measured
The Results section (‘Increased NE descent amplitude primes awakenings over micro-arousals’; page unavailable) reports infraslow norepinephrine oscillations during NREM sleep, supporting the main point. It gives a frequency of 0.034 ± 0.004 Hz, however, rather than approximately 0.02 Hz. (LLM, conf=0.90)
- Partly supportedcites [34] Antila H, Kwak I, Choi A, A noradrenergic-hypothalamic neural substrate for stress-induced sleep disturbances. Proc Natl Acad Sci. 2022; 119(45): 1– 12. doi: 10.1073/pnas.2123528119 PMC9659376 36331996 sourceExperimental — accuracy not yet measured
The Results section, “The Activity of LC-NE Neurons Rhythmically Fluctuates during NREMs” (page unavailable), reports rhythmic LC noradrenergic-neuron activity in sleeping mice peaking at 0.017 ± 0.005 Hz, approximately 0.02 Hz. A separate Results section measures norepinephrine levels in the preoptic area during NREM sleep, but does not establish that the levels themselves oscillate at that frequency throughout the brain. (LLM, conf=0.85)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Panadrenergic inhibition (i.p. administration of the α1-adrenergic receptor antagonist prazosin, the broad β-adrenergic receptor antagonist propranolol, and the α2-adrenergic antagonist atipamezole, PPA13,14) blocked the LC-induced decrease in blood albumin signal (Figure 1H).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE drives state-dependent vasomotion
What the sources say
- Supportedcites [13] Hussain R, Tithof J, Wang W, Potentiating glymphatic drainage minimizes post-traumatic cerebral oedema. Nature. 2023; 623(7989): 992– 1000. doi: 10.1038/s41586-023-06737-7 37968397 PMC11216305 source
The citation is attached to the definition of PPA, not to the subsequent LC-induced albumin result, which the citing sentence assigns to its Figure 1H. The cited paper’s TBI methods (page unavailable) identify PPA as an intraperitoneally administered cocktail of prazosin, propranolol and atipamezole. (LLM, conf=0.90)
- Partly supportedcites [14] Xie L, Kang H, Xu Q, Sleep Drives Metabolite Clearance from the Adult Brain. Science (80-). 2013; 342(6156): 373– 377. doi: 10.1126/science.1241224 PMC3880190 24136970 sourceExperimental — accuracy not yet measured
The passage on adrenergic signaling (section labeled Abstract; page unavailable) reports using a cocktail of adrenergic receptor antagonists, supporting the general description of panadrenergic inhibition. It does not name prazosin, propranolol, or atipamezole; its antagonists were delivered intracisternally or applied to the cortex, not injected intraperitoneally. The LC-induced blood-albumin result is presented as the citing paper’s own Figure 1H result, rather than a finding attributed to this source. (LLM, conf=0.82)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Glymphatic fluid transport is enhanced during sleep14–19.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Introduction
What the sources say
- Supportedcites [14] Xie L, Kang H, Xu Q, Sleep Drives Metabolite Clearance from the Adult Brain. Science (80-). 2013; 342(6156): 373– 377. doi: 10.1126/science.1241224 PMC3880190 24136970 source
The supplied passage [5] states that glymphatic CSF influx was sharply suppressed in awake mice compared with naturally sleeping littermates. This supports enhanced glymphatic fluid transport during sleep in the mice studied. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [15] Hauglund NL, Pavan C, Nedergaard M. Cleaning the sleeping brain – the potential restorative function of the glymphatic system. Curr Opin Physiol. 2020; 15: 1– 6. doi: 10.1016/j.cophys.2019.10.020 source
- Partly supportedcites [16] Eide PK, Vinje V, Pripp AH, Mardal K-A, Ringstad G. Sleep deprivation impairs molecular clearance from the human brain. Brain. 2021; 144(3): 863– 874. doi: 10.1093/brain/awaa443 33829232 sourceExperimental — accuracy not yet measured
The Results report reduced molecular tracer clearance from brain tissue after sleep deprivation, and the Discussion describes sleep-dependent clearance as part of the glymphatic concept. But the Discussion says the observations only may support that concept and that MRI cannot establish the tracer’s exact route; it does not establish that glymphatic fluid transport itself is enhanced during sleep. (LLM, conf=0.82)
- Partly supportedcites [17] Fultz NE, Bonmassar G, Setsompop K, Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science (80-). 2019; 366(6465): 628– 631. doi: 10.1126/science.aax5440 PMC7309589 31672896 sourceExperimental — accuracy not yet measured
The paper reports stronger CSF inflow oscillations during human NREM sleep than during wakefulness (Results, page unavailable) and notes prior findings of increased interstitial fluid volume and waste clearance during sleep (Introduction, page unavailable). It does not directly measure glymphatic transport, so the claim is more specific than this paper’s finding. (LLM, conf=0.84)
- Supportedcites [18] Shokri-Kojori E, Wang G-J, Wiers CE, β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci. 2018; 115(17): 4483– 4488. doi: 10.1073/pnas.1721694115 29632177 PMC5924922 source
The Abstract says that the glymphatic pathway operates most efficiently during sleep, directly supporting the claim. The Discussion identifies rodent findings as evidence for this mechanism; the claim does not specify a human population. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [19] Miyakoshi LM, Stæger FF, Li Q, The state of brain activity modulates cerebrospinal fluid transport. Prog Neurobiol. 2023; 229(June): 102512. doi: 10.1016/j.pneurobio.2023.102512 37482196 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We previously showed that optogenetically stimulated vasoconstriction in anesthetized transgenic mice expressing channelrhodopsin-2 in vascular smooth muscle cells (Sm22-Cre:Ai32-ChR2) directly enhances CSF tracer influx43.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > Optogenetically enhancing the frequency of arterial oscillations potentiates CSF tracer influx
What the sources say
- Supportedcites [43] Holstein-Rønsbo S, Gan Y, Giannetto MJ, Glymphatic influx and clearance are accelerated by neurovascular coupling. Nat Neurosci. 2023; 26(6): 1042– 1053. doi: 10.1038/s41593-023-01327-2 37264158 PMC10500159 source
The Results section, “Optogenetically-induced vasoconstriction increases CSF influx,” reports that stimulating Sm22-Cre:Ai32-ChR2 mice increased CSF tracer signal in the stimulated hemisphere and increased tracer accumulation. The Methods section, “Optogenetic activation of pial arteries,” confirms that these mice were anesthetized and that photoactivation induced arterial constriction. (LLM, conf=0.94)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the finding that vascular volume changes drive CSF flow in the 4th ventricle”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Partly supportedcites [17] Fultz NE, Bonmassar G, Setsompop K, Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science (80-). 2019; 366(6465): 628– 631. doi: 10.1126/science.aax5440 PMC7309589 31672896 sourceExperimental — accuracy not yet measured
The Abstract reports CSF flow measured at the fourth ventricle and a strong temporal relationship between CSF and BOLD oscillations. It proposes that changing blood volume displaces CSF, but presents this as a hypothesis consistent with the data and says causal relationships remain to be tested. Calling it a finding that vascular volume changes ‘drive’ CSF flow overstates the evidence. (LLM, conf=0.88)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“indirectly suggesting that the sympathetic projections from the trigeminal ganglion that innervates the pial arteries likely play a less important role in vascular control during sleep80,81”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Not checked — no full text of the sourcecites [80] Zhang Q-J, Hara H, Kobayashi S. Distribution Patterns of Sensory Innervation from the Trigeminal Ganglion to Cerebral Arteries in Rabbits Studied by Wheat Germ Agglutinin-conjugated Horseradish Peroxidase Anterograde Tracing. Neurosurgery. 1993; 32(6): 993– 999. doi: 10.1227/00006123-199306000-00019 7687045 source
- Partly supportedcites [81] Terrier L, Hadjikhani N, Velut S, The trigeminal system: The meningovascular complex— A review. J Anat. 2021; 239(1): 1– 11. doi: 10.1111/joa.13413 33604906 PMC8197948 sourceExperimental — accuracy not yet measured
Section 3.2 (page unavailable) describes trigeminal innervation of pial arteries and a possible role in cerebral blood-flow control. It distinguishes trigeminal fibres from sympathetic fibres, however, and does not discuss whether either has a lesser role during sleep. (LLM, conf=0.85)
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesEvery source the paper cites for this claim was checked and supports it.
In the paper
“Thus, they contradict a recent publication claiming that glymphatic clearance is inhibited during sleep and enhanced during wakefulness70.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Supportedcites [70] Miao A, Luo T, Hsieh B, Brain clearance is reduced during sleep and anesthesia. Nat Neurosci. Published online May 13, 2024. doi: 10.1038/s41593-024-01638-y PMC11156584 38741022 source
The Main section (page not supplied) reports that brain clearance in mice is reduced during sleep and anesthesia, and contrasts this with earlier claims of increased clearance during sleep. That supports identifying this paper as the publication claiming lower clearance during sleep than wakefulness. (LLM, conf=0.93)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“later studies from the same group documented that infraslow vasomotion is enhanced during sleep76.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Supportedcites [76] Helakari H, Korhonen V, Holst SC, Human NREM Sleep Promotes Brain-Wide Vasomotor and Respiratory Pulsations. J Neurosci. 2022; 42(12): 2503– 2515. doi: 10.1523/JNEUROSCI.0934-21.2022 35135852 PMC8944230 source
The Discussion’s Conclusions state that NREM sleep produces power increases in vasomotor pulsations. The section ‘Vasomotor pulsations dominate during NREM sleep’ also reports enhanced very-low-frequency signals during sleep. (LLM, conf=0.94)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The data so far indicates that CSF flow in the perivascular spaces (PVSs) is driven forward by dynamic constriction and enlargement of the cerebral arteries, and thereby the PVS volume, rather than a steady PVS size27–31.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The frequency of micro-arousals correlates with glymphatic clearance in NREM sleep
What the sources say
- Not checked — no full text of the sourcecites [27] Funk W, Endrich B, Messmer K, Intaglietta M. Spontaneous arteriolar vasomotion as a determinant of peripheral vascular resistance. Int J Microcirc Clin Exp. 1983; 2(1): 11– 25. 6678836
- Not checked — no full text of the sourcecites [28] Hayoz D, Tardy Y, Rutschmann B, Spontaneous diameter oscillations of the radial artery in humans. Am J Physiol Circ Physiol. 1993; 264(6): 2080– 2084. doi: 10.1152/ajpheart.1993.264.6.H2080 8322936 source
- Not checked — no full text of the sourcecites [29] Zhang Z, Khatami R. Predominant endothelial vasomotor activity during human sleep: a near-infrared spectroscopy study. Eur J Neurosci. 2014; 40(9): 3396– 3404. doi: 10.1111/ejn.12702 25156240 source
- Partly supportedcites [30] van Veluw SJ, Hou SS, Calvo-Rodriguez M, Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain. Neuron. 2020; 105(3): 549– 561. doi: 10.1016/j.neuron.2019.10.033 31810839 PMC7028316 sourceExperimental — accuracy not yet measured
The Introduction describes vasomotion as repeated arterial constriction and dilation, and the Discussion reports that stronger vasomotion was associated with greater paravascular clearance in awake mice. But the study measured fluorescent-solute clearance alongside arteries, not forward CSF flow or changes in PVS volume versus a steady PVS size. Its conclusion calls vasomotion a possible motive force rather than establishing the asserted mechanism. (LLM, conf=0.87)
- Partly supportedcites [31] Bojarskaite L, Vallet A, Bjørnstad DM, Sleep cycle-dependent vascular dynamics in male mice and the predicted effects on perivascular cerebrospinal fluid flow and solute transport. Nat Commun. 2023; 14(1): 953. doi: 10.1038/s41467-023-36643-5 36806170 PMC9941497 sourceExperimental — accuracy not yet measured
The Introduction reports reciprocal changes in arteriole and PVS size and says modeling suggests these dynamics facilitate PVS fluid flow. The Results section on predicted PVS fluid velocity reports increased peak velocities during slow oscillations, but says the model does not enforce net flow. Thus the source supports dynamic changes as a driver of fluid movement, not the stronger claim that they drive CSF forward. (LLM, conf=0.86)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- Probably not a substantial claim. 24
- It may state two separate claims as one. 45
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“NE is known to be a potent vasoconstrictor36,37.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Introduction
What the sources say
- Supportedcites [36] Avakian O V, Gillespie JS. Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response. Br J Pharmacol Chemother. 1968; 32(1): 168– 184. doi: 10.1111/j.1476-5381.1968.tb00441.x 5640169 PMC1570308 source
In “Relationship between noradrenaline concentration and fluorescence” (page not provided), the paper reports that noradrenaline produced maximal constriction of isolated arteries at concentrations well below those needed for detectable fluorescence. This supports the cited statement that norepinephrine is a potent vasoconstrictor. (LLM, conf=0.88)
- Partly supportedcites [37] Korte N, James G, You H, Noradrenaline released from locus coeruleus axons contracts cerebral capillary pericytes via α 2 adrenergic receptors. J Cereb Blood Flow Metab. 2023; 43(7): 1142– 1152. doi: 10.1177/0271678X231152549 36688515 PMC10291462 sourceExperimental — accuracy not yet measured
The Results report that noradrenaline constricted cerebral capillaries near pericytes, and the Discussion says it evokes contractile tone in cerebral arterioles and capillaries (page numbers unavailable). This supports its vasoconstrictor action, but the paper does not establish the broader claim that it is a potent vasoconstrictor generally. (LLM, conf=0.82)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The glymphatic system uses the perivascular spaces as low-resistance routes for fast influx of CSF into deep brain regions1.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Introduction
What the sources say
- Partly supportedcites [1] Iliff JJ, Wang M, Liao Y, A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid. Sci Transl Med. 2012; 4(147): 1– 11. doi: 10.1126/scitranslmed.3003748 PMC3551275 22896675 sourceExperimental — accuracy not yet measured
The Results sections on paravascular CSF influx report rapid flow along spaces surrounding arteries into the brain, including the basal ganglia and thalamus. But the paper describes AQP4-mediated movement between paravascular spaces and the interstitium—not the influx spaces themselves—as a low-resistance pathway; it also uses that description for venous efflux. The low-resistance characterization of the influx route is therefore not supported. (LLM, conf=0.85)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, most if not all anesthetic regimens suppress or eliminate the characteristic features of natural sleep, such as oscillatory release of NE, micro-arousals, vasomotion and REM sleep, which renders anesthesia unsuited to dissect the drivers of glymphatic flow in natural sleep38–41.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Introduction
What the sources say
- Not checked — no full text of the sourcecites [38] Colantuoni A, Bertuglia S, Intaglietta M. Effects of anesthesia on the spontaneous activity of the microvasculature. Int J Microcirc Clin Exp. 1984; 3(1): 13– 28. 6480227
- Partly supportedcites [39] Akata T, Kodama K, Takahashi S. Volatile anaesthetic actions on norepinephrine-induced contraction of small splanchnic resistance arteries. Can J Anaesth. 1995; 42(11): 1040– 1050. doi: 10.1007/BF03011080 8590495 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [40] Akeju O, Brown EN. Neural oscillations demonstrate that general anesthesia and sedative states are neurophysiologically distinct from sleep. Curr Opin Neurobiol. 2017; 44: 178– 185. doi: 10.1016/j.conb.2017.04.011 28544930 PMC5520989 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked yetcites [41] Tort-Colet N, Capone C, Sanchez-Vives MV., Mattia M. Attractor competition enriches cortical dynamics during awakening from anesthesia. Cell Rep. 2021; 35(12): 109270. doi: 10.1016/j.celrep.2021.109270 34161772
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The glymphatic system is a highly organized, brain-wide network for cerebrospinal fluid (CSF) transport that exports protein waste, including amyloid and tau1–3.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Introduction
What the sources say
- Partly supportedcites [1] Iliff JJ, Wang M, Liao Y, A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid. Sci Transl Med. 2012; 4(147): 1– 11. doi: 10.1126/scitranslmed.3003748 PMC3551275 22896675 sourceExperimental — accuracy not yet measured
The Discussion (page not supplied) describes a brain-wide glymphatic pathway for CSF transport and interstitial-solute clearance in mice. The Results section on AQP4 (page not supplied) supports clearance of soluble amyloid β, but our copy does not establish tau clearance; a search for “tau” found no relevant passage. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [2] Iliff JJ, Chen MJ, Plog BA, Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury. J Neurosci. 2014; 34(49): 16180– 16193. doi: 10.1523/JNEUROSCI.3020-14.2014 25471560 PMC4252540 source
- Supportedcites [3] Ishida K, Yamada K, Nishiyama R, Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration. J Exp Med. 2022; 219(3): 1– 9. doi: 10.1084/jem.20211275 PMC8932543 35212707 source
The Introduction describes perivascular, AQP4-facilitated transport from brain interstitial fluid into CSF and reports that AQP4 deficiency reduces amyloid-β clearance. The Results and discussion calls the glymphatic system a brain-wide pathway for eliminating extracellular substances and reports that it clears extracellular tau from the brain to CSF. These passages support the cited description, although the paper attributes the amyloid finding to earlier studies. (LLM, conf=0.90)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“glymphatic flow is enhanced by optogenetic stimulation of excitatory neurons in hippocampus across a broad range of frequencies89”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Partly supportedcites [89] Jiang-Xie L-F, Drieu A, Bhasiin K, Quintero D, Smirnov I, Kipnis J. Neuronal dynamics direct cerebrospinal fluid perfusion and brain clearance. Nature. 2024; 627(8002): 157– 164. doi: 10.1038/s41586-024-07108-6 38418877 PMC12054998 sourceExperimental — accuracy not yet measured
The “Synthesized waves enhance CSF-to-ISF perfusion” section reports increased tracer infiltration in the hippocampus after optogenetic stimulation at 1 Hz and 8 Hz. The Methods identify a CaMKIIa-ChRmine vector used for activation. The claim overstates the frequency evidence: the paper tests two stimulation frequencies, not a broad range. (LLM, conf=0.87)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Since it is difficult to control when rodents enter natural sleep, anesthesia is commonly used as a proxy for sleep1,24,99,100.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > Using fiber photometry to study brain fluid dynamics
What the sources say
- Could not verifycites [1] Iliff JJ, Wang M, Liao Y, A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid. Sci Transl Med. 2012; 4(147): 1– 11. doi: 10.1126/scitranslmed.3003748 PMC3551275 22896675 sourceExperimental — accuracy not yet measured
Materials and Methods > Anesthesia says the mice were anesthetized for all experiments, and Results > In vivo imaging describes imaging anesthetized mice (page numbers unavailable). Neither passage says anesthesia was used as a proxy for sleep, that this is common practice, or that controlling the onset of natural sleep is difficult. Searches for those terms found no passage addressing the claim. (LLM, conf=0.76)
- Could not verifycites [24] Mestre H, Tithof J, Du T, Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nat Commun. 2018; 9(1): 4878. doi: 10.1038/s41467-018-07318-3 30451853 PMC6242982 sourceExperimental — accuracy not yet measured
The Methods (Animals and surgical preparation; page unavailable) say the mice were anesthetized with ketamine/xylazine. Our copy does not say anesthesia was used as a proxy for sleep, that this is common practice, or that difficulty controlling natural sleep is the reason. Searches for those terms and for sleep found no passage addressing the claim. (LLM, conf=0.74)
- Not checked — no full text of the sourcecites [99] Lee H, Xie L, Yu M, The Effect of Body Posture on Brain Glymphatic Transport. J Neurosci. 2015; 35(31): 11034– 11044. doi: 10.1523/JNEUROSCI.1625-15.2015 26245965 PMC4524974 source
- Not checked — no full text of the sourcecites [100] Plog BA, Mestre H, Olveda GE, Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain. JCI Insight. 2018; 3(23): 1– 15. doi: 10.1172/jci.insight.126138 PMC6328017 30518698 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“glymphatic flow is partly active in quiet wakefulness, whereas active wakefulness potently suppresses CSF inflow88.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Partly supportedcites [88] von Holstein-Rathlou S, Petersen NC, Nedergaard M. Voluntary running enhances glymphatic influx in awake behaving, young mice. Neurosci Lett. 2018; 662(September 2017): 253– 258. doi: 10.1016/j.neulet.2017.10.035 29079431 PMC5696653 sourceExperimental — accuracy not yet measured
The Results (‘Regional fluorescence intensity differs’; page unavailable) show CSF tracer uptake in awake mice. The Results (‘Wheel running impairs tracer influx’; page unavailable) report that acute running suppressed influx relative to awake behaving, exercised mice. The paper does not establish that the comparator was in quiet wakefulness or that active wakefulness generally suppresses inflow; it tests running specifically. (LLM, conf=0.84)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Common to both studies was the finding that neural synchrony drive glymphatic clearance.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Supportedcites [89] Jiang-Xie L-F, Drieu A, Bhasiin K, Quintero D, Smirnov I, Kipnis J. Neuronal dynamics direct cerebrospinal fluid perfusion and brain clearance. Nature. 2024; 627(8002): 157– 164. doi: 10.1038/s41586-024-07108-6 38418877 PMC12054998 source
The Discussion states that coordinated neuronal firing generates rhythmic ionic waves that facilitate CSF perfusion and metabolic-waste removal. It also reports that rhythmic neuronal oscillations organize brain clearance, supporting the paraphrase that neural synchrony drives glymphatic clearance. (LLM, conf=0.93)
- Partly supportedcites [90] Murdock MH, Yang CY, Sun N, Multisensory gamma stimulation promotes glymphatic clearance of amyloid. Nature. 2024; 627(8002): 149– 156. doi: 10.1038/s41586-024-07132-6 38418876 PMC10917684 sourceExperimental — accuracy not yet measured
The Abstract reports that multisensory 40 Hz stimulation promoted glymphatic fluid movement in a mouse model of Alzheimer’s disease. The Discussion links gamma rhythms to neuronal synchrony but says they “may be relevant” to clearance and that brain rhythms “contribute” to its regulation. Thus, the paper supports a role for stimulated neural rhythms, not the unqualified claim that neural synchrony itself drives glymphatic clearance. (LLM, conf=0.86)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“similar observations have been done in response to sensory gamma stimulation (40 Hz, visual or auditory)90.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Partly supportedcites [90] Murdock MH, Yang CY, Sun N, Multisensory gamma stimulation promotes glymphatic clearance of amyloid. Nature. 2024; 627(8002): 149– 156. doi: 10.1038/s41586-024-07132-6 38418876 PMC10917684 sourceExperimental — accuracy not yet measured
The ‘Gamma stimulation promotes glymphatic clearance’ section reports increased CSF influx and ISF efflux after 40 Hz stimulation in 5XFAD mice. The intervention was multisensory—combined light and sound—so the paper does not establish the claimed effect for visual or auditory stimulation individually. Page numbers were not available in our copy. (LLM, conf=0.86)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Other studies reported divergent observations with regard to the effects of zolpidem on EEG sigma power, micro-arousals and consolidation of memory67,68,95,96.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
What the sources say
- Not checked — no full text of the sourcecites [67] Kopp C, Rudolph U, Tobler I. Sleep EEG changes after zolpidem in mice. Neuroreport. 2004; 15(14): 2299– 2302. doi: 10.1097/00001756-200410050-00031 15371753 source
- Partly supportedcites [68] Uygun DS, Ye Z, Zecharia AY, Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons. J Neurosci. 2016; 36(44): 11171– 11184. doi: 10.1523/JNEUROSCI.3714-15.2016 27807161 PMC5148237 sourceExperimental — accuracy not yet measured
The Results section, “Zolpidem does not induce sleep in γ2I77 lox mice” (page unavailable), reports reduced NREM EEG power at 5–16 Hz in one mouse group but no change in another, supporting divergent observations in a range that includes sigma frequencies. The cited paper does not report effects on micro-arousals or memory consolidation; its discussion of the number of awakenings is not a measure of micro-arousals. (LLM, conf=0.84)
- Not checked yetcites [95] Leong CWY, Leow JWS, Grunstein RR, A systematic scoping review of the effects of central nervous system active drugs on sleep spindles and sleep-dependent memory consolidation. Sleep Med Rev. 2022; 62: 101605. doi: 10.1016/j.smrv.2022.101605 35313262
- Not checked — no full text of the sourcecites [96] Zhang J, Yetton B, Whitehurst LN, Naji M, Mednick SC. The effect of zolpidem on memory consolidation over a night of sleep. Sleep. 2020; 43(11). doi: 10.1093/sleep/zsaa084 PMC8064806 32330272 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Prescription of zolpidem is currently not recommended for individuals older than 65 by the American Geriatric Society93,94.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
What the sources say
- Could not verifycites [93] Shih H-I, Lin C-C, Tu Y-F, An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population. Medicine (Baltimore). 2015; 94(17): e809. doi: 10.1097/MD.0000000000000809 25929937 PMC4603066 sourceExperimental — accuracy not yet measured
The Discussion describes risks of zolpidem use in older adults, and the conclusion calls for careful evaluation and follow-up. Neither passage states an American Geriatrics Society recommendation against prescribing it to people over 65; searches for that recommendation and the Beers criteria found no such statement in our copy. (LLM, conf=0.74)
- Not checked — no full text of the sourcecites [94] Merel SE, Paauw DS. Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care. J Am Geriatr Soc. 2017; 65(7): 1578– 1585. doi: 10.1111/jgs.14870 28326532 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“establishing the connection between vascular dynamics and CSF inflow is important because it provides the mechanistic link between vascular pathology and glymphatic stagnation that may explain the increased risk of Alzheimer’s disease in patients suffering from cardiovascular diseases84,85.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Not checked — no full text of the sourcecites [84] Lennon MJ, Makkar SR, Crawford JD, Sachdev PS. Midlife Hypertension and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. J Alzheimer’s Dis. 2019; 71(1): 307– 316. doi: 10.3233/JAD-190474 31381518 source
- Partly supportedcites [85] Abdulrahman H, van Dalen JW, den Brok M, Latimer CS, Larson EB, Richard E. Hypertension and Alzheimer’s disease pathology at autopsy: A systematic review. Alzheimer’s Dement. 2022; 18(11): 2308– 2326. doi: 10.1002/alz.12707 35758526 PMC9796086 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“zolpidem has previously been shown to increase the risk of reversible dementia and has also been linked to neuropsychiatric adverse events92.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
What the sources say
- Partly supportedcites [92] Mittal N, Mittal R, Gupta MC. Zolpidem for Insomnia: A Double-Edged Sword. A Systematic Literature Review on Zolpidem-Induced Complex Sleep Behaviors. Indian J Psychol Med. Published online 2021. doi: 10.1177/0253717621992372 PMC8450729 34584301 sourceExperimental — accuracy not yet measured
The Abstract’s discussion of key findings links zolpidem to neuropsychiatric adverse events, including hallucinations, delirium, and amnesia. It does not say zolpidem increases the risk of reversible dementia; the Discussion’s Limitations section mentions dementia only as a possible concomitant disorder. (LLM, conf=0.89)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“measurements of CSF dynamics have proven more difficult and have mostly been restricted to experiments in awake and anesthetized mice24.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > Using fiber photometry to study brain fluid dynamics
What the sources say
- Partly supportedcites [24] Mestre H, Tithof J, Du T, Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nat Commun. 2018; 9(1): 4878. doi: 10.1038/s41467-018-07318-3 30451853 PMC6242982 sourceExperimental — accuracy not yet measured
The Methods (Animals and surgical preparation; page unavailable) describe CSF-flow experiments in anesthetized mice, and the Results (Quantifying flow in perivascular spaces; page unavailable) describe how flow was measured. Our copy does not establish that measurements have mostly been restricted to mice, address measurements in awake mice, or explicitly characterize CSF-dynamics measurements as difficult. (LLM, conf=0.83)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“astrocyte endfeet may act as valves that promote CSF flow through the perivascular spaces and prevent backflow86,87.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Not checked yetcites [86] Bork PAR, Ladrón-de-Guevara A, Christensen AH, Jensen KH, Nedergaard M, Bohr T. Astrocyte endfeet may theoretically act as valves to convert pressure oscillations to glymphatic flow. J R Soc Interface. 2023; 20(204): 1– 5. doi: 10.1098/rsif.2023.0050 PMC10336390 37434503
- Supportedcites [87] Gan Y, Holstein-Rønsbo S, Nedergaard M, Boster KAS, Thomas JH, Kelley DH. Perivascular pumping of cerebrospinal fluid in the brain with a valve mechanism. J R Soc Interface. 2023; 20(206): 1– 17. doi: 10.1098/rsif.2023.0288 PMC10509587 37727070 source
The Introduction proposes that astrocyte endfeet act as valves and explains that reduced permeability during artery constriction inhibits reflux from the extracellular space. The Discussion says the modeled valve action promotes directed net flow in perivascular spaces. The claim’s tentative wording matches the paper’s proposed mechanism. (LLM, conf=0.94)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“chronic sleep fragmentation impairs both slow vasomotion and glymphatic function77.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Supportedcites [77] Deng S, Hu Y, Chen S, Chronic sleep fragmentation impairs brain interstitial clearance in young wildtype mice. J Cereb Blood Flow Metab. 2024;(130). doi: 10.1177/0271678X241230188 PMC11418708 38639025 source
The Abstract reports that chronic sleep fragmentation reduced glymphatic function and suppressed slow vasomotion in young wildtype mice. The Discussion likewise reports reduced CSF transport and dampened slow vasomotion after 30 days of sleep fragmentation. (LLM, conf=0.94)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“a hallmark of aging and neurodegenerative diseases is the impairment of functional hyperemia, i.e., vasodilation in response to neural activity83.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Partly supportedcites [83] Zimmerman B, Rypma B, Gratton G, Fabiani M. Age-related changes in cerebrovascular health and their effects on neural function and cognition: A comprehensive review. Psychophysiology. 2021; 58(7): e13796. doi: 10.1111/psyp.13796 33728712 PMC8244108 sourceExperimental — accuracy not yet measured
The section on impaired vasculature (page unavailable) defines functional hyperemia as local vasodilation during neural activity and reports disrupted neurovascular coupling in both normal and pathologically aging humans. It does not establish the impairment as a hallmark of neurodegenerative diseases generally; that wording is broader and stronger than the passage supports. (LLM, conf=0.84)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Most prior studies looking at vascular dynamics have used two-photon imaging in head-fixed mice31,47,98”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > Using fiber photometry to study brain fluid dynamics
What the sources say
- Supportedcites [31] Bojarskaite L, Vallet A, Bjørnstad DM, Sleep cycle-dependent vascular dynamics in male mice and the predicted effects on perivascular cerebrospinal fluid flow and solute transport. Nat Commun. 2023; 14(1): 953. doi: 10.1038/s41467-023-36643-5 36806170 PMC9941497 source
The Methods sections describe two-photon imaging of blood vessels in mice trained to be head-fixed. This paper is therefore an example of the study type cited in the sentence; it does not itself establish how many prior studies used that approach. (LLM, conf=0.90)
- Supportedcites [47] Turner KL, Gheres KW, Proctor EA, Drew PJ. Neurovascular coupling and bilateral connectivity during nrem and rem sleep. Elife. 2020; 9: 1. doi: 10.7554/eLife.62071 PMC7758068 33118932 source
The Results describe this study as using two-photon microscopy to measure vascular dynamics in un-anesthetized, head-fixed mice. The Materials and methods section confirms that the mice were head-fixed while pial and penetrating arterioles were imaged. This source therefore serves as an example of the type of prior study cited, rather than independently establishing that most prior studies used the approach. (LLM, conf=0.88)
- Supportedcites [98] Tsai C-J, Nagata T, Liu C-Y, Cerebral capillary blood flow upsurge during REM sleep is mediated by A2a receptors. Cell Rep. 2021; 36(7): 109558. doi: 10.1016/j.celrep.2021.109558 34407410 source
The In vivo two-photon microscopy section describes imaging capillary blood flow in head-fixed mice using a two-photon microscope. Figure 1 likewise identifies a head-fixed mouse setup for vascular imaging. This paper therefore supports the citation as an example of the method described. (LLM, conf=0.91)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“flow fiber photometry enables recordings from deep brain tissues and combined monitoring of blood and CSF dynamics using virally-delivered biosensors45,101–104.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > Using fiber photometry to study brain fluid dynamics
What the sources say
- Partly supportedcites [45] Feng J, Zhang C, Lischinsky JE, A Genetically Encoded Fluorescent Sensor for Rapid and Specific In Vivo Detection of Norepinephrine. Neuron. 2019; 102(4): 745– 761.e8. doi: 10.1016/j.neuron.2019.02.037 30922875 PMC6533151 sourceExperimental — accuracy not yet measured
The STAR METHODS > METHOD DETAILS section describes fiber-photometry recordings from deep brain regions in mice after viral delivery of a fluorescent norepinephrine sensor. It does not report combined monitoring of blood and CSF dynamics; the recordings described are of brain fluorescence signals. Page numbers are not available in our copy. (LLM, conf=0.88)
- Partly supportedcites [101] Jing M, Li Y, Zeng J, An optimized acetylcholine sensor for monitoring in vivo cholinergic activity. Nat Methods. 2020; 17(11): 1139– 1146. doi: 10.1038/s41592-020-0953-2 32989318 PMC7606762 sourceExperimental — accuracy not yet measured
The Online Methods section, “Fiber photometry, EEG and EMG recordings in mice” (page not provided), describes fiber-photometry recordings in the basolateral amygdala and hippocampus using an AAV-delivered ACh sensor. It does not report combined monitoring of blood and CSF dynamics; its mention of hemodynamic change concerns correction of a recording artifact. (LLM, conf=0.87)
- Partly supportedcites [102] Wan J, Peng W, Li X, A genetically encoded sensor for measuring serotonin dynamics. Nat Neurosci. 2021; 24(5): 746– 752. doi: 10.1038/s41593-021-00823-7 33821000 PMC8544647 sourceExperimental — accuracy not yet measured
The Methods section, “Fiber-photometry recording in mice” (page unavailable), describes optical-fiber recordings from mouse brain regions using AAV-delivered serotonin sensors. The paper supports that part of the sentence, but our copy does not describe combined monitoring of blood and CSF dynamics. (LLM, conf=0.88)
- Partly supportedcites [103] Zhu R, Zhang G, Jing M, Genetically encoded formaldehyde sensors inspired by a protein intra-helical crosslinking reaction. Nat Commun. 2021; 12(1): 581. doi: 10.1038/s41467-020-20754-4 33495458 PMC7835342 sourceExperimental — accuracy not yet measured
The Results section, “Visualization of FA dynamics in mouse brain tissues by FAsors” (page unavailable), describes viral delivery of a fluorescent biosensor to the mouse hippocampus and imaging of formaldehyde responses in acute brain slices. It does not describe flow fiber photometry, recordings from deep brain tissue in vivo, or combined monitoring of blood and CSF dynamics. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [104] Wu Z, He K, Chen Y, A sensitive GRAB sensor for detecting extracellular ATP in vitro and in vivo. Neuron. 2022; 110(5): 770– 782. doi: 10.1016/j.neuron.2021.11.027 34942116 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“a slightly faster 0.05 Hz oscillation in CSF flow was observed in the 4th ventricle of human subjects while sleeping in an MR scanner17 and was temporally directly correlated with autonomic arousals42.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > Translational aspects
What the sources say
- Supportedcites [17] Fultz NE, Bonmassar G, Setsompop K, Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science (80-). 2019; 366(6465): 628– 631. doi: 10.1126/science.aax5440 PMC7309589 31672896 source
Citation 17 is attached to the observation of CSF flow during sleep, not to the separate statement about autonomic arousals, which cites 42. The supplied passages report a 0.05 Hz CSF oscillation during human NREM sleep and describe fMRI measurement with the imaging boundary at the fourth ventricle. (LLM, conf=0.93)
- Supportedcites [42] Picchioni D, Özbay PS, Mandelkow H, Autonomic arousals contribute to brain fluid pulsations during sleep. Neuroimage. 2022; 249(November 2021): 118888. doi: 10.1016/j.neuroimage.2022.118888 35017126 PMC11395500 source
Citation 42 is attached to the temporal association with autonomic arousals, not the 0.05 Hz frequency, which the sentence cites separately. The Results (page unavailable) report CSF inflow events alongside autonomic arousals during sleep, and the Discussion describes an autonomic contribution to CSF pulsations near the fourth ventricle. The relationship is time-lagged rather than simultaneous. (LLM, conf=0.88)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The analysis showed that artery diameter but not vein diameter was highly dynamic and that NE and artery diameter displayed the same state-dependent oscillatory patterns and negative correlation that were observed with fiber photometry (Figure S1I–N).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE drives state-dependent vasomotion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“REM sleep also displayed an oscillatory component but with a faster (0.02–0.03 Hz) frequency, while wakefulness displayed a much slower frequency peak below ~0.005 Hz.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > Infraslow oscillations in NE, cerebral blood and CSF volume are phase-locked during NREM sleep
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“optogenetic inhibition of LC activity by expression of the light-driven proton pump Arch-eGFP in TH-Cre mice decreased the NE signal concurrently with increasing the blood albumin signal.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE drives state-dependent vasomotion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The CSF tracer signal fluctuated dynamically in the opposite direction of the blood albumin signal with a small lag in the blood albumin signal after the CSF tracer signal (0.3±3 seconds in wakefulness, 0.6±0.4 seconds in NREM sleep and 0.5±2.3 seconds in REM sleep) (Figure 2B–D).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE-mediated vasomotion drives state-dependent and anti-correlated fluctuations in CSF
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The increase in CSF was abolished in mice pre-treated with the panadrenergic receptor cocktail, PPA, demonstrating that it is NE that mediates the CSF dynamics via vasoconstriction.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE-mediated vasomotion drives state-dependent and anti-correlated fluctuations in CSF
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Upon LC stimulation, an increase in NE and a decrease in blood albumin signal were consistently noted (Figure 1H).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE drives state-dependent vasomotion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The blood albumin signal lagged after the NE signal by 0.29±0.6 seconds in wakefulness and by 0.69±0.3 seconds in NREM sleep, while a broader time dependency was observed in REM sleep.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE drives state-dependent vasomotion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Power spectral density analysis of NE, blood and CSF signals normalized to the area under the curve showed that all three signals exhibited infraslow oscillations in the 0.01–0.02 Hz range during NREM sleep (Figure 3B).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > Infraslow oscillations in NE, cerebral blood and CSF volume are phase-locked during NREM sleep
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The average CSF tracer level was highest in NREM sleep and lowest in REM sleep (Figure 2E).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE-mediated vasomotion drives state-dependent and anti-correlated fluctuations in CSF
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“our study clearly indicates that zolpidem reduced the latency to sleep, concurrently with potently interfering with the normal sleep architecture and suppressing glymphatic flow in mice.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, glymphatic influx exhibited a positive correlation with the frequency of micro-arousals, while not correlating with total time spent in NREM sleep, NREM delta power, theta power, sigma power or wake episodes > 20 seconds (Figure S4F).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The frequency of micro-arousals correlates with glymphatic clearance in NREM sleep
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Correlation of tracer clearance with basic parameters of sleep showed that neither total time spent in NREM sleep, time spent awake, time spent in REM sleep, nor the number of REM bouts predicted tracer clearance (Figure 5C and Figure S4B).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The frequency of micro-arousals correlates with glymphatic clearance in NREM sleep
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“our analysis clearly showed that zolpidem dampened the power of the NE oscillations and reduced glymphatic CSF tracer inflow (Figure 6).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Administration of 5 mg/kg zolpidem in mice expressing GRABNE2m in the dorsal cortex resulted in a reduction in magnitude the infraslow EEG sigma power oscillation (Figure 6A–B) and sigma power amplitude (Figure S5C) along with a suppression of the infraslow NE oscillation magnitude in NREM sleep (figure 6C).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The sleep aid zolpidem impairs neuronal and vascular oscillations and suppresses CSF tracer inflow
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The analysis showed a distinct pattern with a sharp increase in NE levels, a sharp and transient decrease in blood albumin signal, and a sharp and transient increase in CSF signal.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > Infraslow oscillations in NE, cerebral blood and CSF volume are phase-locked during NREM sleep
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Stimulation of the vascular smooth muscle cells induced a decrease in blood albumin signal in both wakefulness and NREM sleep (Figure S3A) and in a similar range to natural micro-arousals (Figure 4C).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > Optogenetically enhancing the frequency of arterial oscillations potentiates CSF tracer influx
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the hippocampus and the dorsal cortex both exhibited significantly higher tracer penetration in the stimulated hemisphere (Figure 4I–J).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > Optogenetically enhancing the frequency of arterial oscillations potentiates CSF tracer influx
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Clearance was also not correlated with NREM delta power (1–4 Hz), theta power (4–8 Hz), sigma power (8–15 Hz) or beta power (13–20 Hz).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The frequency of micro-arousals correlates with glymphatic clearance in NREM sleep
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“mCherry, GRAB-mut fluorescence and background fluorescence before tracer injection was found to exhibit lower intensity during REM sleep”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Conclusion > Method details
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The observations identify locus coeruleus (LC)-induced NE oscillations as the key mechanism of slow vasomotion and thereby of glymphatic solute clearance during natural sleep.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, both optogenetic activation and inhibition of the LC control the dynamics of the cerebral vasculature.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE drives state-dependent vasomotion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We utilized ‘Flow fiber photometry’ – a technique that combines fiber photometry with blood and CSF tracers and is the first methodology that allows simultaneous longitudinal tracking of the CSF and blood dynamics, while avoiding the use of anesthesia.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE-mediated vasomotion drives state-dependent and anti-correlated fluctuations in CSF
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, CSF and cerebral blood volume exhibit anti-correlated and state-dependent fluctuations that are controlled by NE released by the LC.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > NE-mediated vasomotion drives state-dependent and anti-correlated fluctuations in CSF
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Magnetic resonance encephalography (MREG) mapping of pulsation in the human brain showed already in 2016 that infraslow vasomotion represents an alternative driver of glymphatic flow75”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Not checked — no full text of the sourcecites [75] Kiviniemi V, Wang X, Korhonen V, Ultra-fast magnetic resonance encephalography of physiological brain activity – Glymphatic pulsation mechanisms? J Cereb Blood Flow Metab. 2016; 36(6): 1033– 1045. doi: 10.1177/0271678X15622047 26690495 PMC4908626 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Most prior studies have concluded that vasomotion reflects intrinsic activity of vascular smooth muscle cells78,79.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Not checked — no full text of the sourcecites [78] Vasomotion Intaglietta M. and flowmotion: physiological mechanisms and clinical evidence. Vasc Med Rev. 1990; vmr-1(2): 101– 112. doi: 10.1177/1358836X9000100202 source
- Not checked — no full text of the sourcecites [79] Aalkjær C, Boedtkjer D, Matchkov V. Vasomotion – what is currently thought? Acta Physiol. 2011; 202(3): 253– 269. doi: 10.1111/j.1748-1716.2011.02320.x 21518271 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, vascular volume changes is the pump forcing CSF transport in both the 4th ventricle and within the cortical tissue.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This point towards the conclusion that CSF flow is promoted by NE oscillations, i.e. vasoconstriction, but do not require the presence of micro-arousals.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The frequency of micro-arousals correlates with glymphatic clearance in NREM sleep
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, our results point to a mechanism where LC-mediated NE release drives slow vasomotion, which in turn promotes glymphatic clearance (Figure 7).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The sleep aid zolpidem impairs neuronal and vascular oscillations and suppresses CSF tracer inflow
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“it is difficult to decipher whether zolpidem also suppresses NE dynamics in human subjects.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
Strength:hedged· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Anesthesia potently suppresses NE release and vasomotion71–73”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The evolving insight into what drives CSF flow in the sleeping brain
What the sources say
- Not checked — no full text of the sourcecites [71] Mefford IN, Garrick NA. Effects of xylazine on cerebrospinal fluid catecholamines in the rhesus monkey. Brain Res. 1989; 492(1–2): 377– 380. doi: 10.1016/0006-8993(89)90923-2 2568878 source
- Not checked — no full text of the sourcecites [72] Ambrisko TD, Hikasa Y. Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs. Can J Vet Res. 2002; 66(1): 42– 49. 11858648 PMC226981
- Not checked yetcites [73] Kanda T, Hikasa Y. Neurohormonal and metabolic effects of medetomidine compared with xylazine in healthy cats. Can J Vet Res. 2008; 72(3): 278– 286. 18505192 PMC2327246
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, the frequency of micro-arousals displayed a stronger correlation with glymphatic influx and clearance than all other measures of sleep analyzed, including total amount of NREM sleep and NREM delta power, suggesting that NE oscillations is the main determinant of glymphatic clearance in NREM sleep.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The frequency of micro-arousals correlates with glymphatic clearance in NREM sleep
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, zolpidem dampens the infraslow NE dynamics of sleep, which suppresses CSF tracer influx, despite increasing the duration of sleep.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The sleep aid zolpidem impairs neuronal and vascular oscillations and suppresses CSF tracer inflow
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, the observations indicate that glymphatic influx is not correlated with statically high NE (wakefulness) or statically low NE (REM sleep), but depends on the dynamic NE release that occurs in NREM sleep for optimal flow.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The frequency of micro-arousals correlates with glymphatic clearance in NREM sleep
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A key difference between natural and pharmacologically supported sleep is that boosting of inhibitory transmission dramatically alters the microarchitecture of sleep, possibly by direct suppression of LC activity, and thereby the NE oscillations characteristic of NREM sleep.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, correlation analysis, as well as optogenetic stimulation or inhibition of LC, or direct stimulation of vascular smooth muscle cells, as well as indirect manipulations of slow vasomotion (zolpidem) document that it is the infraslow NE oscillations that triggers slow vasomotion, which in turn is the primary driver of glymphatic flow in NREM sleep (Figure 7).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, the observed increase in micro-arousal and decrease in glymphatic influx support that it is infraslow NE oscillations, and not micro-arousals, that drive CSF flow.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Results > The sleep aid zolpidem impairs neuronal and vascular oscillations and suppresses CSF tracer inflow
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Zolpidem (Ambien) is a high-affinity positive modulator of GABAA receptors, that enhances GABAergic transmission by binding to the alpha1 subunit91.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
What the sources say
- Not checked — no full text of the sourcecites [91] Kralic JE, O’Buckley TK, Khisti RT, Hodge CW, Homanics GE, Morrow AL. GABAA receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharmacology. 2002; 43(4): 685– 694. doi: 10.1016/S0028-3908(02)00174-0 12367614 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“these drugs are associated with considerable adverse effects and an increased risk of early mortality97.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > The negative effects of the sleep aid, zolpidem, on NE oscillations and glymphatic flow
What the sources say
- Not checked — no full text of the sourcecites [97] Lohela TJ, Lilius TO, Nedergaard M. The glymphatic system: implications for drugs for central nervous system diseases. Nat Rev Drug Discov. 2022; 21(10): 763– 779. doi: 10.1038/s41573-022-00500-9 35948785 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For the glymphatic clearance study (Figure 5), mice that spent less than 75 minutes of the 5 hours (25% of the time) between scans in sleep were omitted from the analysis (1 mouse).”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Conclusion > Statistical analysis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Mice with excessive noise on the EEG signal were excluded from EEG power analyses.”
- Also stated in: § Statistical analysis · plain
“For all analysis of EEG power, mice were omitted if EEG power analysis could not be performed due to too noisy signals.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Conclusion > Method details
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Also stated in: § Statistical analysis · plain
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The limits of detection (at signal-to-noise-ratio 3) for NE, concentrations were 12 fmol/10 μl.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Conclusion > Method details
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the sleep aid zolpidem impaired the NE dynamics that characterize normal restorative sleep resulting in reduced glymphatic flow.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Conclusion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“our observations that directly links NE release to slow vasomotion and CSF flow.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Discussion > Translational aspects
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For the glymphatic influx study (Figure S4), mice that spent less than 20 of the 30 minutes circulation time in sleep were omitted from the analysis (2 mice) in order to obtain enough sleep data.”
§ Norepinephrine-driven slow vasomotion drives glymphatic clearance in sleep > Conclusion > Statistical analysis
Strength:plain· not yet calibratedn = 2Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
The brain relies on cerebrospinal fluid circulation through the tissue to remove waste proteins because it lacks lymphatic vessels.
“Due to the lack of lymphatic vessels, the brain relies on CSF circulation through the tissue to remove waste proteins.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While pharmacologic treatments for insomnia are generally given reduced recommendations in clinical guidelines due to concerns about dependence and cognitive side effects, 47 , 48 , 49 , 50 our findings suggest possible differences in associations with cognitive outcomes across hypnotics, and further investigation is warranted.”
From Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation (2026) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting zolpidem doses for the marble-burying test
MinorThe results describe pilot testing at 1 and 5 mg/kg, including the marble-burying test, and the marble-burying method gives those same doses. The drug-preparation method instead says the test used 5 and 10 mg/kg.
“Pilot experiments comparing the effects of 1 mg/kg and 5 mg/kg zolpidem66,67,69 showed that a 5 mg/kg dose decreased mobility after the injection without a marked effect on the marble burying test the next day”
“For the marble burying test, mice received 5 mg/kg or 10 mg/kg i.p.”
Baseline microdialysis sample count does not match sampling interval
MinorSamples were obtained every 20 minutes, so a 20-minute baseline would yield one sample, not the stated two.
Reported 2 · recomputed 1
“The first 20 minutes (2 samples) mice were left undisturbed to establish baseline values before drug treatment.”
Conflicting SPECT acquisition and reconstruction peak energies
MinorThe acquisition specifies a 1200 keV detection peak, whereas reconstruction specifies a photopeak window centered at 140 keV. These are conflicting energies for the stated SPECT photopeak.
“SPECT was acquired as 1 frame of 15 minutes covering the full body of the mouse (11 positions) with detection peak energy of 1200 keV.”
“SPECT images were reconstructed with a photopeak window centered around 140 keV with 20% width.”
Citations
Cites
Yushkevich, P. A., Piven, J., Hazlett, H. C., Smith, R. G., Ho, S., Gee, J. C., & Gerig, G. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.015 · Cited by 8,868
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Self-citationSleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Self-citationShaner, N. C., Campbell, R. E., Steinbach, P. A., Giepmans, B. N. G., Palmer, A. E., & Tsien, R. Y. (2004) · Nature Biotechnology · doi:10.1038/nbt1037 · Cited by 4,619
Impairment of paravascular clearance pathways in the aging brain
Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., Xie, L., Kang, H., Xu, Q., Liew, J. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24271 · Cited by 1,521
Self-citationCerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
Iliff, J. J., Wang, M., Zeppenfeld, D. M., Venkataraman, A., Plog, B. A., Liao, Y., Deane, R., & Nedergaard, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1592-13.2013 · Cited by 1,319
Self-citationCoupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep
Fultz, N. E., Bonmassar, G., Setsompop, K., Stickgold, R. A., Rosen, B. R., Polimeni, J. R., & Lewis, L. D. (2019) · Science · doi:10.1126/science.aax5440 · Cited by 1,197
Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury
Iliff, J. J., Chen, M. J., Plog, B. A., Zeppenfeld, D. M., Soltero, M., Yang, L., Singh, I., Deane, R., & Nedergaard, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3020-14.2014 · Cited by 1,159
Self-citationYaffe, K., Laffan, A. M., Harrison, S. L., Redline, S., Spira, A. P., Ensrud, K. E., Ancoli-Israel, S., & Stone, K. L. (2011) · JAMA · doi:10.1001/jama.2011.1115 · Cited by 1,137
Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension.
Mestre, H., Tithof, J., Du, T., Song, W., Peng, W., Sweeney, A. M., Olveda, G., Thomas, J. H., Nedergaard, M., & Kelley, D. H. (2018) · Nature Communications · doi:10.1038/s41467-018-07318-3 · Cited by 1,110
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Kanda, 2008, Neurohormonal and metabolic effects of medetomidine compared with xylazine in healthy cats, Can. J. Vet. Res., 72, 278
Cited by
Sorted by citations
Items 201–300 of 349
Sheybani, L. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf072
Cherrad, N., Foustoukos, G., Fernandez, L. M. J., Osorio-Forero, A., Emmenegger, Y., Franken, P., & Lüthi, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.14.643122
Krakow, B. J., & Krakow, J. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.03.014
Notre cerveau se nettoie pendant le sommeil
Bohler, S. (2025) · Cerveau & Psycho · doi:10.3917/cerpsy.174.0006
The infuriating, expensive road to a good night’s sleep
Nuwer, R. (2025) · Nature · doi:10.1038/d41586-025-00965-9
Zhang, C., Yang, Y., Li, F.-N., Zhang, H., Sun, L., Li, J., Yang, C., Yue, Z.-F., Feng, J., Li, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.11.659024
Green light to sleep: Does cannabis work for insomnia? A case report and brief review
Mota-Rolim, S. A., Melo, P. D. C., Barroso, V. V., do Amaral, E. J. F., Araújo, J. F., & Ribeiro, S. T. G. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.07.005
Baranyai, L., Iotchev, I. B., Gombos, F., & Kis, A. (2025) · Animals · doi:10.3390/ani15213182
Imaging natural variations of BBB function
Wang, D. J. J., & Shao, X. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32974-6.00003-3
Impact of Alzheimer’s Disease Associated Peptides on Sleep-Wake State
Harjani Tirathdas, L. (2025) · UCL Discovery (University College London)
Hemmerich, F. H. (2025) · Preprints.org · doi:10.20944/preprints202512.1660.v1
Hemmerich, F. H. (2025) · Preprints.org · doi:10.20944/preprints202512.1660.v2
Effects of different slow paced breathing regimes on cerebrospinal fluid (CSF) oscillationsPreprint
Nasseri, P., Banks, M., Li, A. Y., Lewis, L. D., Yoo, H. J., & Mather, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.24.696312
Antila, H., Jalonen, S. C., Persson, N. D. Å., Peltoniemi, M., Lohela, T. J., & Lilius, T. O. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110828
Fishing for the neurovascular code
Rauscher, B. C., & Devor, A. (2026) · Neuron · doi:10.1016/j.neuron.2025.12.016
Gayger-Dias, V., Krebs-Rosa, J., Bobermin, L. D., Quincozes‐Santos, A., & Gonçalves, C. (2026) · CNS Drugs · doi:10.1007/s40263-025-01269-2
Hauglund, N. L., Mukherji, R., Zhou, X., Hoerder‐Suabedissen, A., Mao, R., Peirson, S. N., Herwig, A., Deboer, T., & Vyazovskiy, V. V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.25.701526
Self-citationAn Atlas of Electroencephalographic Infraslow Oscillation Features During Sleep in a Clinical Cohort
Luo, E. T., Sun, H., Zeng, T. H., & Tremsina, E. A. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11356864
Barcellini, F., Foustoukos, G., Wenz, D., Munn, B., Shine, J. M., Fernandez, L. M. J., Lüthi, A., & Zerbi, V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.28.702261
Chary, P., Rehmani, S., Davidson, S., Li, X., Chen, S. X., & Silasi, G. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.1818-25.2026
Vicious circle of amyloid and leptomeningeal macrophages evokes vascular dysfunction in CAAPreprint
Hartantyo, R. Y., Tsuji, T., Hou, L., Saito, R., Yamasaki, A., Kochi, T., Saito, Y., Tada, M., Cheung, D. L., Moorhouse, A. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.12.705483
Actualités 2025 en neurosciences fondamentales
Rancillac, A. (2026) · Médecine du Sommeil · doi:10.1016/j.msom.2026.01.007
Kim, J. (2026) · Headache and Pain Research · doi:10.62087/hpr.2026.0003
Locus Coeruleus: Uyku-Uyanıklık Döngüsünde Nöroanatomik Bir Anahtar
Uçan, S. G. (2026) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.1730487
Jacobsen, S. S., Morehouse, A. B., Chen, P., Qian, Y., Gomolka, R. S., Andersen, M., Nedergaard, M., Mednick, S. C., & Kjærby, C. (2026) · eLife · doi:10.7554/elife.110252
Self-citationDong, Z., Zhao, R., Zhang, Q., Song, Z., Zhu, H., Liu, Y., & Tang, Z. (2026) · Science of Traditional Chinese Medicine · doi:10.1097/st9.0000000000000101
Li, L., Zhang, H., Gao, Y., Khan, S. J., Wu, F., Ren, X., Zhang, J., Bedane, K. H., Jian, L., Zang, W., et al. (2026) · Behavioral and Brain Functions · doi:10.1186/s12993-026-00325-1
Wang, J., Wang, Y., Cai, M., Zhang, X., Yu, X., Zhao, G., & Dong, H. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.108915
Makulec, G., Domosud, K., Zienkiewicz, D., Ostaszewska, M., Walendziak, W., Mordal, N., Ściebura, K., Wiśniewska, W., Majchrzyk, M., & Malczyk, A. (2026) · Quality in Sport · doi:10.12775/qs.2026.53.70258
Fang, X., Yang, C., Zhou, R., Hu, L., Li, Q., Wang, C., Su, K., Dai, X., Zhang, R., Zhou, Y., et al. (2026) · Regenesis repair rehabilitation. · doi:10.1016/j.rerere.2026.04.001
Dérivation ventriculaire externe : gestion au quotidien
Perrault, T., Lomo, H., Gaillard, T., D, J.-M. L. M., & Lasocki, S. (2026) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2026.02.003
von Fingerhut, G., Makino, K., Osuka, Y., Ito, K., Kato, T., Satake, S., & Shimada, H. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71123
Laurén, K., Järvelä, M., Huotari, N., Raitamaa, L., Kananen, J., Tuunanen, J., Väyrynen, T., Korhonen, V. O., Hautamäki, K., Hurtig, T. M., et al. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.121908
Shan, Z., Zhu, Q., Wang, S., Xia, Y., Yang, Y., & Tian, L. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117155
Aquaporin‐4 in Narcolepsy Type 1: Investigation of Perivascular Fluid Movement in Sleep Disorders
Ranke, J., Steinacker, P., Halbgebauer, S., Oeckl, P., Mayer, G., & Otto, M. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70398
Tort‐Colet, N., Stankeviciute, L. S., Fernández‐Arcos, A., Soldevila‐Domenech, N., Sánchez‐Benavides, G., Shekari, M., García, D. V., Altomare, D., Barkhof, F., Boada, M., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02049-w
From run-to-failure to condition-based care: a multi-domain framework for preventive psychiatry
Alaoui, S. E. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1821471
Les astrocytes, intégrateurs centraux multiéchelles des états de vigilance
Rancillac, A. (2026) · médecine/sciences · doi:10.1051/medsci/2026054
Pfoser-Poschacher, V., Wolf, M., Bayerle‐Eder, M., Wimmer, T., Boryshchuk, D., Gerner, C., & Wolzt, M. (2026) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.70092
Cho, G., Kam, K., Chen, A., Mao, Y., Benveniste, H., Mecca, A. P., Valencia, D. I., Martillo, K., Chu, S. S. H., Kumar, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.25.720853
Liu, J., Wang, Y., Cheng, G., Zhao, H., Hui, R., Li, M., Dang, Y., Liu, M., Guo, B., Su, S., et al. (2026) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2026.100301
Ignatavicius, A., Konuri, A., Churchill, L., Anderson, J., Halliday, G. M., Lewis, S. J. G., & Matar, E. (2026) · medRxiv · doi:10.64898/2026.05.13.26353090
Pourmotabbed, H., & Chang, C. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2608470123
Spontaneous cortical vasodynamics form a multiscale propagation architecture across the awake brainPreprint
Liu, X., Zhou, X. A., Hike, D., Duckworth, J. C., Pasupathy, N., Jiang, Y., Choi, S., Fu, Z., Rosen, B. R., Kleninfeld, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.19.726296
Mayer, A., Wick, T. V., Nathaniel, U., Ryman, S. G., Kumar, D. S., Mannix, R., Miller, S., Ling, J. M., Meier, T. B., Warren, K., et al. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261453862
Katsuki, F., McNally, J. M., Gerashchenko, D., Uygun, D. S., Tyler, A., McCoy, J. G., McKenna, J. T., & Brown, R. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.725476
The glymphatic system in stroke and small vessel disease: an emerging therapeutic target
Chavda, V. K., Patel, M., Bhrambhatt, R., Stary, C. M., Avula, C., Ahmed, N., Montemurro, N., & Chaurasia, B. K. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00650-x
Dyupin, A. V., Egorova, I., & Chervotok, A. E. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.112025
Obstructive Sleep Apnea Syndrome Disrupts Glymphatic-Related Physiological Brain PulsationsPreprint
Huuskonen, U., Santaniemi, N., Juntunen, O., Myllylä, T., Korhonen, V. O., Kinnunen, M. T., Starck, T., Tenhunen, M. L., Himanen, S., Kallio, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.02.729357
Impact of DSP4-induced locus coeruleus dysfunction on sleep: Systematic review and methodology
Knopper, R. W., & Hansen, B. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107457
JI, R., Zhang, L., Yu, J., Wang, B., Zhang, L., Shang, D., Cao, Y., Hu, J. W., Liu, H., Rong, J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9647623/v1
Nächtliche Prozesse halten gesund
Freund, W. (2026) · NeuroTransmitter · doi:10.1007/s15016-026-4243-9
Tulin, R. F., Oprea, Ș., Enyedi, M., Dumitru, A. V., & Dumitrescu, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125202
Comment le cerveau se nettoie pendant le sommeil
Jacquemont, G., & Denworth, L. (2026) · Pour la Science · doi:10.3917/pls.584.0052
Comment notre cerveau se nettoie pendant notre sommeil
Proff, I. (2026) · Cerveau & Psycho · doi:10.3917/cerpsy.188.0070
The electrofluidic brain as a basement layer for neural computation
Chakravarthy, V. S., Chandrasekaran, V., & Shanbhag, N. C. (2026) · Communications Biology · doi:10.1038/s42003-026-10444-0
Edem, E. E., Soja, S. B., Abba, M. R., Chinyere, K. F., & Enye, L. A. (2026) · Biomedicines · doi:10.3390/biomedicines14061376
REM sleep as a dummy-model of the world: A theoretical framework
Censi, S. T., Granzotto, A., & Sensi, S. L. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102939
Gao, Y., Liang, W., Wang, G., Xu, Z., Liu, Y., Wang, Y., Wang, Y., Zhang, Y., Deng, Y., Zhou, J., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261462893
Exercise as a regulator of glymphatic function
Broatch, J. R., Saner, N. J., JACKSON, M., Syeda, W. T., Bishop, D. J., & Brodtmann, A. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.06.002
Castañeyra-Perdomo, A., González–Mora, J. L., Goulis, S., Ilmoniemi, R. J., Lioumis, P., Makris, N., & Pallanti, S. (2026) · Applied Sciences · doi:10.3390/app16136593
Meinhold, L., Kaandorp, M., Shang, Z., Häuselmann, M., Volk, C., Treyer, V., Huber, R., Michels, L., Gruber, E., Studer, S. T., et al. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122096
Noya, S. B., Yang, J., Yue, Z., Nguyen, A., Guevara, C., GIANANI, S. R., XU, V., Pivarshev, P., Williams, J. A., LU, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.736189
Chen, L., Ao, C., Zhang, S., Zhang, X., & Li, Z. (2026) · BMC Public Health · doi:10.1186/s12889-026-28448-0
Brain clearance physiology in traumatic brain injury: From disruption to therapeutic potential
Shanbhag, N. C., Reyes, J. S., Larson, S., Bragina, O. A., Kibria, F., Stevens, A. R., Gerber, K. S., Cardoso, F. D. S., Milligan, T., Gitlevich, T. R., et al. (2026) · The Journal of Physiology · doi:10.1113/jp291237
Brain oscillations and sleep microarchitecture: From EEG to fMRI
Kumar, A. A., Trasorras, E. C., Haitham, N., Qatanany, B., Sharafkhaneh, A., Rao, K. S. J., & Nami, M. (2026) · Progress in brain research · doi:10.1016/bs.pbr.2026.07.003
Ortega, R. S., & Strauss, M. (2026) · Journal of Sleep Research · doi:10.1111/jsr.70404
Flow in a porous non-axisymmetric annular conduit: Coupling wall compliance and peristalsis
Surianarayanan, N., & Christov, I. C. (2026) · Journal of Fluid Mechanics · doi:10.1017/jfm.2026.12064
Yao, Q., Han, X., Cui, T., Li, D., Shan, A., Wang, X. G., Li, S., Luan, H., Zhu, Y., Wen, B., et al. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13997-6
Jackson, B. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1895931
The glymphatic system and Parkinson’s disease: a narrative review
Acaroğlu, M. A., Abdelghaffar, T., Samancı, B., Zirh, A. T., Samancı, Y., & Yılmaz, N. H. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09291-y
Xie, M., Wu, S., Yang, L., & Zhang, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1895597
Agust韓, C.-P., Jose.Luis, G.-M., Ilmoniemi, R. J., Makris, N., & Pallanti, S. (2026) · Immune discovery. · doi:10.70322/immune.2026.10006
Sleeping in cycles within cycles: A nonlinear framework for NREM sleep microstructure
Silvani, A., Sicbaldi, M., Mogavero, M. P., Lanza, G., Quercia, A., Bruni, O., Ceccanti, S., Rosenzweig, I., & Ferri, R. (2026) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2026.102351
Jacobsen, S. S., Morehouse, A. B., Chen, P., Qian, Y., Gomolka, R. S., Andersen, M., Nedergaard, M., Mednick, S. C., & Kjærby, C. (2026) · eLife · doi:10.7554/elife.110252.2.sa0
Self-citationJacobsen, S. S., Morehouse, A. B., Chen, P., Qian, Y., Gomolka, R. S., Andersen, M., Nedergaard, M., Mednick, S. C., & Kjærby, C. (2026) · eLife · doi:10.7554/elife.110252.2
Self-citationDifferential effects of P2Y12 inhibition on sleep and glymphatic function in male and female mice
Su, L., Tian, M., Zhang, S., Gao, P., Zhang, X., 谢敏杰, Liu, X., Xu, W., & 姚恩生 (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101330
Brendstrup‐Brix, K., Iversen, O. B., Ferdinando, H., Moradi, S., Bergmann, M., Pernet, C. R., Myllylä, T., Larsen, S. M. U., & Knudsen, G. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.743907
Dodart, C.-A. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261474020
Dynamic DWI detects respiratory modulation of brain parenchymal hydrodynamics
Zhang, J., Foster, E., Wright, A. M., Zhou, X., & Wen, Q. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1369
Kinetic analysis of CSF–brain tracer exchange in the pig brain under different anesthetic regimesPreprint
Navarro, M. L., Olsen, A. S., Larsen, S. M. U., Madsen, C. A., de Nijs, R., Bubulovic, K., Søndergaard, J., Pernet, C. R., Jørgensen, L. M., Svarer, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.24.746655
Wu, Y., Wang, H., Wang, M., Ren, P., & Zhang, S. (2026) · Ultrasonics · doi:10.1016/j.ultras.2026.108282
Xu, L.-J., Huang, L.-Y., Tang, S., Zou, J., Tan, C., Tan, L., & Xu, W. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106978
Wu, D., Fu, L., Guo, J., Wu, J., Lei, Z., & Li, Y. (2026) · BMC Psychology · doi:10.1186/s40359-026-05481-7
Ding, S., Yang, J., Wang, Z., Bai, R., Yin, K., Jin, L., Kueckelhaus, M., Meuth, S. G., Xiao, M., & Hu, G. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00579-9
Cerebral blood flow in conscious rats and implications for therapeutic interventions
Emans, T. W., Brighouse, C. R., Sloan, J. T., & McBryde, F. D. (2026) · Experimental Physiology · doi:10.1113/ep093381
Sleep and stress as modifiable drivers of Alzheimer’s disease
Wear, D., Hussaini, S. A., & Yu, W. H. (2026) · npj Dementia · doi:10.1038/s44400-026-00127-2
Qi, L., Wang, W., Abdullah, R., Zhao, Y., Wang, Z., Tang, Y., Luo, B., & Peng, G. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71806
Apter, D., Elberse, J. D., Stankeviciute, L. S., Weis, S., Elmenhorst, D., Iliff, J. J., Eickhoff, S. B., Heller, C., & Tahmasian, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.04.749189
Amplitude of physiological brain pulsations in Alzheimer’s diseasePreprint
Perkiömäki, V., Raitamaa, L., Mattila, H., Elabasy, A., Huotari, N., Väyrynen, T., Tuunanen, J., Helakari, H., Järvelä, M., Kananen, J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9725762/v1
Convergent connectivity of sleep disorders and its neurotransmitter and cell enrichment correlatesPreprint
Afshani, M., Saberi, A., Reimann, G. M., Chu, C., Elmenhorst, D., Lotter, L. D., Valk, S. L., Dukart, J., Genon, S., Mueller, V. I., et al. (2026) · medRxiv · doi:10.64898/2026.09.09.26362596
Gray, C., Hu, K., Tse, D., Dieterle, K., Simpson, S., Ruhl, T., Duff, K., Kim, D., Mirzaee, M., Volker, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.04.749497
Mao, Y., Pan, B., Liu, X., & Initiative, T. A. D. N. (2026) · Nature Communications · doi:10.1038/s41467-026-77748-x
Metadata
- Authors
- Hauglund, N. L., Andersen, M., Tokarska, K., Radovanovic, T., Kjaerby, C., Sørensen, F. L., Bojarowska, Z., Untiet, V., Ballestero, S. B., Kolmos, M. G., Weikop, P., Hirase, H., & Nedergaard, M.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Nedergaard, Maiken
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2025-02
- Volume
- 188
- Issue
- 3
- Pages
- 606-622.e17
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC12340670
- OpenAlex
- W4406155654
- Semantic Scholar
- 3637e1fc04948670cb2efbfa832f77cd587ec9da
- Cited by
- 349
- References
- 118
- Citations by year
- 2026: 229 · 2025: 119
- FWCI
- 186.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 370 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Simons Foundation (811237)
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- Independent Research Fund Denmark (0134-00107B, 3101-00282B)
- Lundbeck Foundation (114955, R386-2021-165)
- NIH (U19NS128613, AT011439, R01A 012707)
- EU Joint Programme – Neurodegenerative Disease Research
- Cure Alzheimer's Fund
- Novo Nordisk Foundation (NNFOC0058058, NNF23OC0082427, NNF20OC0066419)
- Human Frontier Science Program (RGP0036)
- Army Research Office (MURI W911NF1910280)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- glymphatic system, norepinephrine, vasomotion, NREM sleep, cerebrospinal fluid flow, cerebral blood volume, locus coeruleus, optogenetic stimulation, zolpidem, brain waste clearance, sleep-dependent memory consolidation
- MeSH terms
- Zolpidem, Glymphatic System, Animals, Brain, Cerebrospinal Fluid, Cerebrovascular Circulation, Locus Coeruleus, Male, Mice, Inbred C57BL, Norepinephrine, Sleep, Mice, Optogenetics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review